TRENDING TOPICS
3055 articles found for "investing"
Morningstar's February report shows the technology sector trading at a 16% discount to fair value, the deepest discount of any major sector, after a brutal selloff in software and AI names.
Uber stock dropped 5.2% after Q4 2025 earnings per share of 71 cents missed estimates by 10%, revealing that cheaper ride options are compressing margins even as revenue hits $14.37 billion.
Tech giants are signing multi-billion-dollar deals for nuclear power as AI data centers devour electricity. Constellation Energy, Microsoft, and Meta are leading a buildout not seen in half a century.
The Russell 2000 has surged more than 7% in 2026, outpacing the S&P 500 as investors rotate out of mega-cap tech and into smaller, domestically focused companies.
Bitcoin has crashed from its October 2025 peak of $126,000 to below $61,000, losing more than half its value in four months as ETF outflows accelerate and leverage unwinds.
With 59% of S&P 500 companies reporting, Q4 2025 earnings are growing 10.1% year-over-year. But the revenue beat rate has fallen to 65%, below the five-year average.
The Dow surged 2.6% to cross 50,000 for the first time while the Nasdaq fell 1.9%. Here's what the biggest divergence between old and new economy stocks in years means for your portfolio.
Microchip Technology reports Q3 FY2026 EPS of $0.44, beating estimates, as revenue rises 15.6% year-over-year to $1.186 billion. Strong guidance points to a broadening semiconductor recovery beyond AI chips.
The Dow Jones Industrial Average crossed 50,000 for the first time in history on Friday, surging 1,207 points in Wall Street's best session since May as chip stocks rallied and consumer sentiment surprised to the upside.
The Russell 2000 surged more than 3% on Friday as small-cap and value stocks extended their outperformance, with the index now up over 7% for 2026 while the Nasdaq struggles to break even.
Four biotech companies — Eikon Therapeutics, SpyGlass Pharma, AgomAb Therapeutics, and Veradermics — went public this week raising nearly $1 billion combined, in the strongest biotech IPO surge since 2021.
MarketAxess reports record revenue of $846 million for 2025 as electronic bond trading volumes surge, with portfolio trading up 126% and emerging markets hitting all-time highs.